- Loungers CEO offloads 130,000 shares
- Celebrus Technologies director buys 50,000 shares
- Harwood Capital director snaps up £30,000 EKF Diagnostics' shares
CEO of Loungers (LGRS:AIM) Nick Collins has sold 130,000 shares at 221p for a total value of £287,300 on 9 January.
Following the sale Collins has 956,276 ordinary shares representing 0.92% of the issued ordinary shares.
Loungers’ shares are up 13% over the past year.
Collins’ move comes as no surprise, as the neighbourhood café/bar restaurant group recently reported a strong set of results for the 24 weeks ending 1 October 2023 when the company announced they had opened 16 new sites in this period.
Loungers – the Bristol-based operator of Lounge, Cosy Club and Brightside cafes and bars - added that they are on track to open 34 new sites for the year end, making a total so far of 256 sites.
Loungers shares up 3% as strong first half sales growth and expansion plans excite investors
Collins could be ‘cashing in’ on the recent impressive performance with revenue increases of 22.3% and 23.6% in earnings before interest, tax, depreciation, and amortisation for the 24 weeks ending 1 October 2023.
CELEBRUS TECHNOLOGIES DIRECTOR BUYS £50,000 SHARES
Tom Skelton non-executive chair elect of Celebrus Technologies (CLBS:AIM) has bought 50,000 shares at 216p for a total value of £107,970 on 9 January.
Following the transaction, Skelton’s total beneficial holding represents 0.12% of the company’s total voting rights.
Celebrus, a disruptive data technology platform has seen shares rise 9% year-to-date.
The company has recently won multiple software contract wins for the December quarter which could be a reason for its recent upward share price movements.
Contract wins include a UK bank (which is using a bespoke version of Celebrus) and the other a new customer in the US healthcare sector.
Skelton’s move could be a vote of confidence in the data solutions provider known for its hosted service Celebrus Cloud.
HARWOOD CAPITAL DIRECTOR BUYS 100,000 SHARES
Christopher Mills, non-executive director of Harwood Capital has bought 100,000 shares at 30p in testing device maker EKF Diagnostics (EKF:AIM) for a total value of £30,000 on 9 January.
This purchase brings Mills total direct and interest in the company to 132,250,000 ordinary shares representing 29.1% of the total voting rights over the company’s issued share capital – just shy of a mandatory takeover.
LEARN MORE ABOUT LOUNGERS